Lilly will acquire Verve Therapeutics for $1.3 billion, focusing on one-time cardiovascular treatments.
From Yahoo Finance: 2025-06-23 01:40:00 Lilly will acquire Verve Therapeutics, Inc. for up to $1.3 billion, offering $10.50 per share
Author: MarketNewsData
Your go-to source for real-time financial news and market analysis. Powered by AI. Covering earnings, economic events, and corporate news.
10x Genomics settles patent dispute with Bruker, receives $68 million settlement
From Yahoo Finance: 2025-06-23 01:39:00 10x Genomics, Inc. settles patent dispute with Bruker, receiving $68 million in quarterly installments from
Barclays starts BioMarin with Buy rating due to long-term potential in genetic therapies portfolio.
From Yahoo Finance: 2025-06-23 01:38:00 Barclays analyst Gena Wang maintains a Buy rating on BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) with a
Positive
From Yahoo Finance: 2025-06-23 01:38:00 uniQure N.V. (NASDAQ:QURE) is one of the 11 Best Genomics Stocks to Buy According to
Exact Sciences expands Oncodetect test validation, plans to introduce new MRD test in 2026.
From Yahoo Finance: 2025-06-23 01:37:00 Exact Sciences Corporation (NASDAQ:EXAS) is recognized as one of the 11 Best Genomics Stocks to
First patient dosed in Phase 3 trial for ION582 to treat Angelman Syndrome
From Yahoo Finance: 2025-06-23 01:37:00 In a pivotal Phase 3 REVEAL trial, Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) doses first participant with
Canaccord raises price target for Illumina, Inc. (ILMN) due to potential revenue growth
From Yahoo Finance: 2025-06-23 01:35:00 Canaccord Genuity analyst Kyle Mikson raised Illumina, Inc. (ILMN) price target from $87 to $99
UBS lowers price target on REGN due to short-term concerns, mixed updates, and Eylea franchise issues.
From Yahoo Finance: 2025-06-23 01:34:00 UBS has reduced its price target on Regeneron Pharmaceuticals, Inc. (REGN) from $633 to $560,
European stocks set to open lower after US strikes in Iran, causing global economic concerns.
From NASDAQ.: 2025-06-23 01:33:00 European stocks are set to open lower after the U.S. attacked three Iranian nuclear facilities, prompting
Holcim completes spin-off of North American business Amriez, with mixed market reactions
From Yahoo Finance: 2025-06-23 01:27:00 Holcim completes spin-off of North American business Amrize, valued at $30 billion in early trading
Amrize completes spin-off from Holcim and debuts on NYSE as an independent publicly traded company
From Nasdaq: 2025-06-23 01:13:00 Amrize Ltd (AMRZ) has officially become an independent, publicly traded company after completing a 100 percent
Novartis' HSR waiting period for acquiring Regulus Therapeutics Inc. has expired
From GlobeNewswire: 2025-06-23 01:00:00 Novartis has announced the expiration of the waiting period under the HSR Act for its tender
Low-volatility stocks face challenges with shrinking demand, declining earnings, and low returns on capital.
From StockStory Media: 2025-06-23 00:42:00 StockStory provides insights into low-volatility stocks that may not offer market-beating returns. UniFirst (UNF) has
Indian shares fall sharply due to U.S. bombing in Iran, leading to concerns over wider conflict.
From Nasdaq: 2025-06-23 00:41:00 Indian shares dropped sharply as the U.S. bombed nuclear sites in Iran, sparking fears of wider
Michael Saylor hints at more Bitcoin purchases despite $5.9 billion strategy losses
From Cointelegraph June 23, 2025 12:16:00 am: Michael Saylor hints at more Bitcoin purchases for Strategy despite a $5.9 billion
Microsoft stock has doubled since 2023 due to increased demand for Azure and AI investments.
From Nasdaq: 2025-06-23 00:06:00 Microsoft stock (NASDAQ:MSFT) has seen a 15% year-to-date gain, outperforming the S&P 500 index due to
Investors question paying premium for Philip Morris stock over Google due to stronger financials.
From Nasdaq: 2025-06-23 00:06:00 Investors are questioning why anyone would pay 37 times earnings for Philip Morris stock when Google
SoFi stock surged 15% due to Chime's IPO, but may be overvalued at $15
From Nasdaq: 2025-06-23 00:06:00 SoFi stock has surged over 15% in the past month, influenced by Chime’s successful IPO. Despite
Intel's new 18A process aims to compete with TSMC's 2nm technology, facing tough challenges.
From Nasdaq: 2025-06-23 00:05:00 Intel is investing heavily in its foundry business, with over $90 billion spent in the past
FedEx will report earnings with mixed reactions in the past, historical data available for analysis.
From Nasdaq: 2025-06-23 00:05:00 FedEx will report fiscal Q4 2025 earnings on June 24. Stock reactions to earnings have been
Factors driving Alphabet stock rise include revenue growth, AI innovation, and increased profitability
From Nasdaq: 2025-06-23 00:05:00 Google’s stock (NASDAQ:GOOG) has fallen 7% YTD, underperforming the S&P 500 due to regulatory scrutiny and
Tapestry stock surged 27% year-to-date, but may be overvalued and lacks strong fundamentals.
From Nasdaq: 2025-06-23 00:05:00 Luxury fashion house Tapestry (NYSE: TPR) has surged 27% year-to-date, outperforming the S&P 500 and peer
Gilead Sciences faces FDA clinical hold but maintains profitability focus, undervalued compared to S&P 500.
From Nasdaq: 2025-06-23 00:05:00 Despite facing an FDA clinical hold on HIV treatment trials, Gilead Sciences (NASDAQ:GILD) has seen a
Archer Aviation stock surges 200% due to demand for air taxi, global expansion, alliances
From Nasdaq: 2025-06-23 00:05:00 Archer Aviation (NYSE: ACHR) stock has surged over 200% in the past year due to strong
BP stock has risen 7% YTD despite lower Q1 profit, positioned well with oil focus.
From Nasdaq: 2025-06-23 00:05:00 BP plc stock (NYSE: BP) has risen about 7% year-to-date, trading at around $32 per share.